Seznam literatury :

1. Niederle P. Hodnocení viability myokardu - stále aktuální problém. Cor Vasa 2002;44:166-167.
2. Tamaki N, Yonekura Y, Mukai T, et al. Stress thallium-201 transaxial computed  tomography: Quantitative versus qualitative analysis for evaluation of coronary artery disease. J Am Coll Cardiol 1984;4:1213-21.
3. Mahmarian JJ, Boyce TM, Goldberg RK, et al. Quantitative exercise thallium-201 single photon emission computed tomography for enhanced diagnosis of ischemic heart disease. J Am Coll Cardiol 1990;15:318-29.
4. DePasquale EE, Nody AC, DePuey EG, et al. Quantitative rotational thallium-201 tomography for identifying and localizing coronary artery disease. Circulation 1988;77:316-327.
5. Brown, K. A. Prognostic Value of a Nuclear Cardiology Techniques. In: Gerson MC. Cardiac Nuclear Medicine. 3rd edition, New York: McGraw Hill, 1997, 619-654.
6. Meluzín J. Postavení zátěžových testů v diagnostice nemoci koronárních tepen a při posuzování její prognózy. Cor Vasa 1997;39:44-49,105-110.
7. Kósa I, Blasini R, Schneider-Eicke J, et al: Myocardial Perfusion Scintigraphy to Evaluate Patients After Coronary Stent Implantation. J Nucl Med 1998; 39:1307-1311.
8. Milan E, Zoccarato O, Terzi A, Ettori F, Leonzi O, Niccoli L, Giubbini R. Technetium- 99m-sestamibi SPECT to detect restenosis after successful percutaneous coronary angioplasty. J Nucl Med 1996; 37:1300-1305.
9. Strauss HW, Miller DD, Wittry MD, et al. Procedure Guideline for Myocardial Perfusion Imaging. J Nucl Med 1998;39:918-23.
10. Klocke FJ, Baird MG, Beverly HL, et al. ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging – Executive Summary. Circulation 2003;108:1404-1418.
11. Underwood SR, Godman B, Salyani S, Ogle J, Ell PJ. Economics of Myocardial Perfusion Imaging in Europe - The Empire Study. Eur Heart J 1999;20:157-166.
12. Levin DC, Parker L, Intenzo CHM, Sunshine JH. Recent Rapid Increase in Utilization of Radionuclide Myocardial Perfusion Imaging and Related Procedures: 1996-1998 Practise Patterns. Radiology 2002;222:144-148.
13. Kamínek M, Mysliveček M, Hušák V, Lang O, Fikrle A. Nukleární kardiologie v České republice v r. 2003: významný nárůst počtu SPECT vyšetření myokardiální perfuze. Cor Vasa 2005;47(4):155-157.
14. Prvulovich E, Metcalfe MJ. Nuclear cardiology in the UK: activity and practice 1997. Eur J Nucl Med 2002;29:553-558.
15. Hachamovitch R. Clinical value of combined perfusion and function imaging in the diagnosis, prognosis, and management of patients with suspected or known coronary artery disease. In: Germano G, Berman DS. Clinical gated cardiac SPECT, Armonk, New York: Futura Publishing Company, Inc., 1999:239-258.
16. Taillefer, R., Tamaki, N. New Radiotracers in Cardiac Imaging. Principles and Applications. Stamford - Connecticut, USA. Appleton & Lange, 1999.
17. Kamínek M, Mysliveček M, Hušák V, Kubinyi J, Lang O, Záhlava J. Metody zátěže používané v nukleární kardiologii. Cor Vasa 2000;42(1):40-46.
18. Mysliveček M, Kamínek M. Doporučení k provádění zátěžových testů v nukleární kardiologii. Cor Vasa 2000;42(3): K54-56.
19. Follansbee WP. Alternatives to Leg Exercise in the Evaluation of Patients with Coronary Artery Disease: Functional and Pharmacologic Stress Modalites. In: Gerson MC. Cardiac Nuclear Medicine. 3rd ed. New York: McGraw-Hill,1997:193-235.
20. Cosín-Sales J, Maceira AM, García-Velloso MJ, Macías A, Gimenez M, García-Bolao I, a spol. Safety and feasibility of  atropine added to submaximal exercise stress testing with Tl-201 SPECT for the diagnosdis of myocardial ischemia. J Nucl Cardiol 2002;9:581-6.
21. De Lorenzo A, Foerster J, Sciammarella MG,Suey C, Hayes SW, Friedman J,D, et al. Use of atropine in patients with submaximal heart rate during exercise myocardial perfusion SPECT. J Nucl Cardiol 2003; 10:51-5.
22. Diamond, G. A., Forrester, J. S. Analysis of probabilty as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979;300:1350-1358.
23. Van Train KF, Garcia EV, Maddahi J, et al. Multicenter trial validation for quantitative analysis of  same-day rest-stress technetium-99m-sestamibi myocardial tomograms. J Nucl Med 1994;35:609-618.
24. Bachmann R, Sechtem U, Voth E, Schröder J, Höpp HW, Schicha H. Dipyridamole Scintigraphy and Intravascular Ultrasound After Successful Coronary Intervention. J Nucl Med 1997;38:553-558.
25. Gerson MC. Tets Accuracy, Test Selection, and Test Result Interpretation in Chronic Coronary Artery Disease. Gerson MC. In: Cardiac Nuclear Medicine. 3/e. New York: McGraw-Hill,1997:527-79.
26. Kamínek M, Mysliveček M, Škvařilová M, Hušák V, Lang O. Neinvazivní detekce ischemické choroby srdeční zobrazením myokardiální perfúze - srovnání fyzické zátěže a infuze dipyridamolu. Cor Vasa 1999;41(4):180-185.
27. Casanova R, Patroncini A, Guidalotti PL, et al. Dose and test for dipyridamole infusion and cardiac imaging early after uncomplicated myocardial infarction. Am J Cardiol 1992;70:1402-6.
28. Santana-Boado C, Candell-Riera J, Castell-Conesa, et al. Diagnostic Accuracy of Technetium-99m-MIBI Myocardial SPECT in Women and Men. J Nucl Med 1998;39:751-755.
29. Azzarelli S, Galassi AR, Foti R, et al.: Accuracy of 99mTc-tetrofosmin myocardial tomography in the evaluation of coronary artery disease. J Nucl Cardiol 1999;6(2):183-189.
30. Iskandrian AS, Heo J, Nguyen T, et al. Assessment of coronary artery disease using single -photon emission computed tomography with thallium-201 during adenosine -induced coronary hyperemia. Am J Cardiol 1991;67:1190-1194.
31. Lisbona R, Linh L, Derbekyan V, Novales-Diaz JA. Supine and Prone SPECT Tc-99m MIBI Myocardial Perfusion Imaging for Dipyridamol Studies. Clin Nucl Med 1995;20:674-677.
32. Francisco DA, Collons SM, Go RT, et al. Tomographic thallium-201 myocardial perfusion scintigrams after maximal coronary artery vasodilation with dipyridamole: Comparison of qualitative and quantitative approaches. Circulation 1982;66:370-379.
33. Huikuri HV, Korhonen UR, Airaksinen J, et al. Comparison of dipyridamole -handgrip test and bicycle exercise test for thallium tomographic imaging. Am J Cardiol 1988;61:264-268.
34. Nguyen T, Heo J, Ogilby JD, et al. Single photon emission computed tomography with thallium-201 during adenosine-induced coronary hyperemia: Correlation with coronary angiography, exercise thallium imaging and two-dimensional echocarrdiography. J Am Coll Cardiol 1990;16:1375-1383.
35. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996;93(5):905-914.
36. Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97(6):535-543.
37. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. J Nucl Cardiol 2002;9: 240-245.
38. Hachamovitch R, Berman DS, Lewin H, et al. Incremental prognostic value of gated SPECT ejection fraction in patients undergoing dual isotope exercise or adenosine stress SPECT. J Nucl Med 1998;39: 101P.
39. Sharir T, Geramano G, Kavangh PB, et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 1999;100:1035-42.
40. Heiba SI, Santiago J, Mirzaitehrane M, Jana S, Fuat D, Abdel-Dayem HM. Transient postischemic stunning evaluation by stress gated Tl-201 SPECT myocardial imaging: effect on systolic left ventricular function. J Nucl Cardiol 2002;9:482-90.
41. Sharir T, Bacher-Stier C, Dhar S, et al. Identification of severe and extensive coronary artery disease by postexercise regional wall motion abnormalities in Tc-99m sestamibi gated single-photon emission computed tomography. Am J Cardiol. 2000;86(11):1171-5
42. Yamagishi H, Shirai N, Yoshiyama M, et al. Incremental value of left ventricular ejection fraction for detection of multivessel coronary artery disease in exercise 201Tl gated myocardial perfusion imaging. J Nucl Med 2002;43:131-9.
43. Shirai N, Yamagishi H, Yoshiyama M, et al. Incremental value of regional wall motion for for detection of multivessel coronary artery disease in exercise 201Tl gated myocardial perfusion imaging. J Nucl Med 2002;43:443-450.
44. Johnson LL, Verdesca SA, Aude WY, et al. Postischemic stunning can afect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms. J Am Coll Cardiol 1997;30:1641-8.
45. Paul AK, Hasegawa S, Yoshioka J, et al. Exercise-induced stunning continues for at least one hour: evaluation with quantitative gated single-photon emission tomography. Eur J Nucl Med 1999;26:410-5.
46. Marcassa CC, Campini R, Calza P, Galli M, Terazzi A, Maugeri S. Evolution of nuclear cardiology: its role in the current clinical practice. J Nucl Cardiol 2003;10:S44.
47. Dilsizian V. Myocardial Viability: A Clinical and Scientific Treatise. Armonk, New-York, Futura Publishing Company, Inc. 2000.
48. Wackers FJTh, Brown KA, heller GA, Kontos MC, Tatum JL, Udelson JA, et al. American Socienty of Nuclear Cardiology position statement on radionuclide imaging in patients with suspected acute ischemic syndromes in the emergency department or ches pain center. J Nucl Cardiol 2002;9: 46-50.
49. Gerson MC, Hoit BD. Comparison of stress myocardial perfusion imaging and stress echocardiography in assessment of coronary artery disease. In: Gerson, M. C.: Cardiac Nuclear Medicine, Third edition, New York: McGraw-Hill, 1997, 581-607.
50. Bax JJ, Poldermans D, Schinkel AF, Boersma E, Elhendy A, Maat A, et al. Perfusion and contractile reserve in chronic dysfunctional myocardium: relation to functional outcome after surgical revascularization. Circulation. 2002; 106: I14-8.
51. Bax JJ, Maddahi J, Poldermans D, Elhendy A, Cornel JH, Boersma E, et al. Sequential (201)Tl imaging and dobutamine echocardiography to enhance accuracy of predicting improved left ventricular ejection fraction after revascularization. J Nucl Med. 2002; 43: 795-802.
52. Kamínek M, Škvařilová M, Ostřanský J, et al. Transient postischemic stunning evaluation by gated SPECT has the potential to detect patients with multivessel coronary artery disease: Validation of the 4D-MSPECT software. Eur J Nucl Med 2003;30 (Suppl.):S254.
53. Kamínek M, Lang O, Hušák V, Mysliveček M. Atlas nukleární kardiologie. Praha, Lacomed spol s r.o., 2003, s. 34.
54. Mysliveček M, Hušák V, Koranda P. Rovnovážná radionuklidová ventrikulografie. In: Nukleární medicína I., UP Olomouc, 2000: 93 - 98.
55. Bianco JA, Wilson MA. Radionuklide Ventriculography. In: Wilson MA. Textbook of Nuclear Medicine. Philadelphia: Lippincot-Raven Publishers, 1998: 137-151.
56. Borer JS, Supino P. Equilibrium Imaging. In: Iskandrian, A. E., Verani, M. S. Nuclear Cardiac Imaging, 3rd Edition. Oxford University Press, Inc. 2003: 346-367.
57. Zaret BL. Cardiac Performance. In: Zaret BL, Beller GA. Clinical Nuclear Cardiology, 3rd Edition. Philadelphia, Mosby, 2005: 175-188.
58. Mysliveček M, Hušák V, Koranda P. Radionuklidová angiokardiografie (metoda prvního průtoku). In: Nukleární medicína I., UP Olomouc, 2000: 98 - 104.
59. Williams KA. First-Pass Radionuclide Angiography. In: Iskandrian, A. E., Verani, M. S. Nuclear Cardiac Imaging, 3rd Edition. Oxford University Press, Inc. 2003: 323-345.